Drug General Information
Drug ID
D06MIQ
Former ID
DCL000887
Drug Name
MRE-0094
Drug Type
Small molecular drug
Indication Diabetic foot ulcer [ICD9: 707; ICD10:L88-L89] Phase 2 [536297]
Company
Aderis Pharmaceuticals Licensee; King Pharmaceuticals
Structure
Download
2D MOL

3D MOL

Formula
C18H20ClN5O5
Canonical SMILES
C1=CC(=CC=C1CCOC2=NC3=C(C(=N2)N)N=CN3C4C(C(C(O4)CO)O)O)<br />Cl
InChI
1S/C18H20ClN5O5/c19-10-3-1-9(2-4-10)5-6-28-18-22-15(20)12-16(23-18)24(8-21-12)17-14(27)13(26)11(7-25)29-17/h1-4,8,11,13-14,17,25-27H,5-7H2,(H2,20,22,23)/t11-,13?,14+,17-/m1/s1
InChIKey
WUCQGGOGHZRELS-OVHGWZCWSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Adenosine A2a receptor Target Info Agonist [536297]
KEGG Pathway Rap1 signaling pathway
Calcium signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Vascular smooth muscle contraction
Parkinson's disease
Alcoholism
Pathway Interaction Database HIF-2-alpha transcription factor network
PathWhiz Pathway Intracellular Signalling Through Adenosine Receptor A2a and Adenosine
Reactome NGF-independant TRKA activation
Adenosine P1 receptors
G alpha (s) signalling events
Surfactant metabolism
WikiPathways Nucleotide GPCRs
Monoamine Transport
GPCRs, Class A Rhodopsin-like
NGF signalling via TRKA from the plasma membrane
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 536297Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24.
Ref 536297Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.